TCM
MRK icon

Towercrest Capital Management’s Merck MRK Stock Holding History

Towercrest Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Sell
9,225
-21
-0.2% -$2.42K 0.17% 52
2025
Q4 		$973K Buy
9,246
+45
+0.5% +$4.22K 0.15% 56
2025
Q3 		$772K Buy
9,201
+76
+0.8% +$6.26K 0.12% 60
2025
Q2 		$722K Sell
9,125
-20
-0.2% -$1.59K 0.13% 55
2025
Q1 		$821K Hold
9,145
– – 0.16% 48
2024
Q4 		$910K Sell
9,145
-36
-0.4% -$3.71K 0.15% 52
2024
Q3 		$1.04M Hold
9,181
– – 0.17% 53
2024
Q2 		$1.14M Sell
9,181
-189
-2% -$24.3K 0.19% 49
2024
Q1 		$1.24M Buy
9,370
+499
+6% +$61.5K 0.21% 48
2023
Q4 		$967K Sell
8,871
-15
-0.2% -$1.56K 0.17% 50
2023
Q3 		$915K Buy
8,886
+35
+0.4% +$3.77K 0.18% 53
2023
Q2 		$1.02M Buy
8,851
+36
+0.4% +$4.09K 0.19% 51
2023
Q1 		$938K Buy
8,815
+7
+0.1% +$756 0.2% 50
2022
Q4 		$977K Hold
8,808
– – 0.22% 49
2022
Q3 		$759K Hold
8,808
– – 0.18% 50
2022
Q2 		$803K Hold
8,808
– – 0.18% 50
2022
Q1 		$723K Hold
8,808
– – 0.14% 55
2021
Q4 		$675K Sell
8,808
-50
-0.6% -$3.98K 0.12% 54
2021
Q3 		$665K Buy
8,858
+972
+12% +$73.9K 0.13% 55
2021
Q2 		$613K Sell
7,886
-379
-5% -$28.2K 0.12% 53
2021
Q1 		$608K Sell
8,265
-1,407
-15% -$104K 0.13% 50
2020
Q4 		$755K Hold
9,672
– – 0.17% 48
2020
Q3 		$766K Hold
9,672
– – 0.19% 47
2020
Q2 		$714K Hold
9,672
– – 0.19% 48
2020
Q1 		$710K Sell
9,672
-1,217
-11% -$95.6K 0.21% 49
2019
Q4 		$945K Buy
10,889
+3,268
+43% +$268K 0.24% 47
2019
Q3 		$612K Hold
7,621
– – 0.17% 49
2019
Q2 		$609K Buy
7,621
+472
+7% +$36.1K 0.17% 49
2019
Q1 		$567K Sell
7,149
-440
-6% -$32.9K 0.16% 49
2018
Q4 		$553K Hold
7,589
– – 0.18% 50
2018
Q3 		$514K Hold
7,589
– – 0.15% 53
2018
Q2 		$440K Buy
+7,589
New +$428K 0.14% 61

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Towercrest Capital Management's MRK Position: Q1 2026 in Review

Towercrest Capital Management reduced its Merck (MRK) stake by 0.23% in Q1 2026, selling an estimated $2.42K and leaving 9,225 shares worth $1.11M. The position accounts for 0.17% of the portfolio, ranked #52.

Towercrest Capital Management first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.24M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Towercrest Capital Management held 9,225 shares of Merck worth $1.11M as of Q1 2026.
  • Towercrest Capital Management sold 21 Merck shares in Q1 2026, an estimated $2.42K.
  • Merck made up 0.17% of Towercrest Capital Management's portfolio in Q1 2026, its #52 holding.
  • Towercrest Capital Management first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
  • Towercrest Capital Management's Merck position peaked at $1.24M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Towercrest Capital Management's 13F filing for Q1 2026, filed 1 May 2026.